相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Economic Evaluation: Simulation of the Cost-Effectiveness and Cost-Utility of Universal Prevention Strategies Against Osteoporosis-Related Fractures
Leon Nshimyumukiza et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients
S. Gamsjaeger et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer
Giuseppe Sergi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
Steven Boonen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women
M. Osaki et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Direct Healthcare Costs of Osteoporosis-Related Fractures in Managed Care Patients Receiving Pharmacological Osteoporosis Therapy
Hema N. Viswanathan et al.
Applied Health Economics and Health Policy (2012)
Detecting Early Biomechanical Effects of Zoledronic Acid on Femurs of Osteoporotic Female Rats
Evandro Pereira Palacio et al.
JOURNAL OF OSTEOPOROSIS (2012)
The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis
Jawl-Shan Hwang et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study
Serge Ferrari et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women
P. S. M. Lai et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid
S. L. Silverman et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Vertebral fracture assessment using a semiquantitative technique
Harry K. Genant et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older
Steven Boonen et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density
Richard Eastell et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Effects of Strontium Ranelate in Asian Women with Postmenopausal Osteoporosis
J. S. Hwang et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures
Gerolamo Bianchi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Loss of treatment benefit due to low compliance with bisphosphonate therapy
F. J. A. Penning-van Beest et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
Michael McClung et al.
BONE (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
The molecular mechanism of nitrogen-containing bisphosphonates as anti osteoporosis drugs
Kathryn L. Kavanagh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis
JS Hwang et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
JA Cramer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Effects of alendronate on osteopenic postmenopausal Chinese women
ML Yen et al.
BONE (2000)
分享论文
